# Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-28 15:29 UTC · Category: Business · Sources: 6 · Current Velocity: 18.37

## Intelligence Brief
"Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss" developed substantial multi-source reporting across the Business sector, tracked across 5 distinct newsrooms by Newsylist.


Key reporting was led by Eli Lilly, Reuters, USA Today and ABC News - Breaking News, Latest News and Videos. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles ?
Coverage spiked when 5 independent newsrooms published 5 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Investor's Business Daily | The Next Ozempic? Lilly's Reta Trounces Novo Powerhouse In Head-To-Head Test | 2026-10-28 11:45 | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxOU3ZFLUt2Z3lKOEpSeERfcGRVb0ZBNWNoc0s4VUh2WUlza0RqWXRRdDBIeHFyNzJYbzI4WEs3dFVJZWtuM1ZkTVcwZFEwYmVmUkJfdGVPQlhEN0paMUNNWW5wMVQyNnFnTkVGWWlSTUs0a0tyMG42bDBUdkRfNGVIZTY4WEtMckp6S1JNdnVWcXoxeTlOUER6T2lHVzY?oc=5) |
| Eli Lilly | Lilly's retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in head-to-head trial | 2026-10-28 11:45 | [Source Link](https://news.google.com/rss/articles/CBMivgFBVV95cUxNYk5FbDBjYW5zTnlROFhkSkRpMlRVb0RsZGQtejd4a3F3bTJtbDU3XzFRbjhTZW51N05qaXhFTWxtd1NKemt1VnNNTjRmZ0Fib3NCNUVVbDlSTmM3Wl9zeDRvQWRaNVppN0gwLXdpZkktTUl0U183SlQ2eVFIcGgyUDZZUlEtMHVtaWU3V08tWGRYX0psaXBlVnRWUlN6UHdBbTZLSlhOaEItdkpkMXJ2VXR2NFdZWjN6aFR1czFn?oc=5) |
| Reuters | Lilly's retatrutide outshines Ozempic on weight loss, blood sugar control in trial | 2026-10-28 11:45 | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxNZ0hwalh5b1g1NFZERG9jUUhSdzNwWHN1RHgyd2JwLXFKRHotc3l5S1JJZ3lpNHJYdGFpb2M1dG8zNzhfeXNjd0ZRUHN2bklUNlo1S05iVjZsbjhUQzlsMUJyLXVCSlNjamtTY2tWRVl3aVhXcXdnc3pEY0tFQ2JrYXdBTFJ1SGlSenllamh2M0JJNTIzQ1Y0WVhuamtIODBGRkFXbzZxRnAxclFvREp6V0pxaFVabnpXZTBQQ2xTTFlGaGlDcFZxMQ?oc=5) |
| USA Today | Retatrutide beats Ozempic on weight loss, blood sugar control, study says | 2026-10-28 11:45 | [Source Link](https://news.google.com/rss/articles/CBMi1AFBVV95cUxPcmtubEp0WTNJVndmRVV4YmMxZHFwZUpfcUNYdm4wQk1ZVWNGMTA5R0tRYXBUeHRBcjgwbDZ3WnVHV2I1eEZXZ0FrcTZpdmVLVThfYm5OLVNnSjdqdnRLdlZXOWxLeWV4R0ZiS3U3ejB1U2lvaW1jb1hjNDJPUXZfcTc2blY5MG0yNjhEWU82ZnhwSkRTVXBBQ3ladWxfUXdFVmhtWW5ZRWxIZk1UeXR2Mkc3OHBkOWt3VE5Vb2dUYVNpQkJtQTY3UXZZVno1M1NpVkFFUg?oc=5) |
| ABC News - Breaking News, Latest News and Videos | New weight loss drug retatrutide provides double the weight loss of Ozempic, Lilly says | 2026-10-28 11:45 | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxNRU9xZWNDTzF1aFlDZDhDakN3VEhRWGNkNW1vazVNcmZ2ck5zLUducGRNQkVVZzhXaXI1NlZqNm9tRmtUZUNxT0luV2lTem1halp0bHg3aHUxUmVTVHV0MXdKYmpmQm82enRaVDRGVjJ5QTVUelhnRzVyNFQyOHBXU0MtZmRabkJhMjJVUHc4MlZfTlg0X0lGb3FYMlV6dUJRUDlLQ1V2SWdMNEwzcE5Z0gG0AUFVX3lxTE1KOFBNejNDZ1pmandiWkphZmpJRG1tdWZsZllVZFh0djJ2NWdzT2kybmNZd01memtqekFxc2IwZGNTUzljSE9LUGZ6R0dVTWZyUUR0TTY5dmZfSnVqNlJ2eEZTdHlwR0R0UzdKbi0yakZab0xNdW9wWTRVOVdvQWdMcTVYMURETjhyY05zN081RjNoZWFINHdKT2YwdnZDWTc3SjN) |
| Business Insider | Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss | 2026-10-28 11:45 | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxONFp4S0s4Z0hOQXhHZnIwU3ZDYjBhWmxVdWQ0VDRzTExoT1Z1VXc2YnBObTFEQjRQSWdYb0xNLTEycl96cFhrbDgxX0RWMGpLMFpfMTk0cTRoOTducU04ck1MQVRMRmJHNDRyaXUtZzJwd1ZOWDFVN1RGT1k5NlNUd3BGTGRXTTFHVnl6RVd6SlFIZ0o0QzJDUnNsZm82WEFrSmhQTXMtX1NJeS16LWJGV0Npaw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-28/bye-bye-ozempic-eli-lilly-says-its-new-drug-retatrutide-more-than-doubles*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*